MPT Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 365 facilities and approximately 37,000 licensed beds in nine countries and across three continents as of September 30, 2026. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. is based in Alabama, Birmingham. Medical Properties Trust, Inc. was incorporated in 2003 in Maryland.…
Industry Peers
REIT - Healthcare FacilitiesKey Statistics
About Medical Properties Trust (NYSE: MPT)
›
Medical Properties Trust (NYSE: MPT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the REIT - Healthcare Facilities industry, part of the Real Estate sector, and reports about 121 employees.
The shares were at 1.640 USD on 19 November 2026, down 65.7% over 52 weeks. Its 52-week range is 1.480 USD to 6.470 USD: the price is 74.7% below the high and 10.8% above the low.
At a market capitalisation of 965.80M USD, it trades at 3.9 times trailing earnings. The median trailing P/E of its 15 largest REIT - Healthcare Facilities peers is 25.6, a discount of 85% for MPT. It pays a dividend yielding 22.09% (it pays out 86% of its earnings), against a median of 5.72% among the dividend payers in that peer group.
Medical Properties Trust reports return on equity of -6.0%, an operating margin of 59.7% and revenue down 5.4% year over year.
Its debt exceeds its cash by 8.66B USD, a debt-to-equity ratio of 2.13. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 3.550 USD is 116.5% above the current price. The next earnings report is expected on 18 February 2027.